{
    "organizations": [],
    "uuid": "a7ee72376e37a5b359d499670f3af4f7c08422cc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cellectar-announces-issuance-of-us/brief-cellectar-announces-issuance-of-u-s-patent-covering-clr-131-use-in-multiple-myeloma-idUSFWN1RG0FZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Cellectar Announces Issuance Of U.S. Patent Covering CLR 131 Use In Multiple Myeloma",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 3 (Reuters) - Cellectar Biosciences Inc:\n* CELLECTAR ANNOUNCES ISSUANCE OF U.S. PATENT COVERING CLR 131 USE IN MULTIPLE MYELOMA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-03T20:21:00.000+03:00",
    "crawled": "2018-04-04T12:22:17.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "cellectar",
        "bioscience",
        "inc",
        "cellectar",
        "announces",
        "issuance",
        "patent",
        "covering",
        "clr",
        "use",
        "multiple",
        "myeloma",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}